ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "SF36"

  • Abstract Number: 0365 • ACR Convergence 2025

    Clinical Characteristics and Psychosocial Outcomes of Patients with UCTD Compared to SLE

    Caroline Siegel1, Yongjay Kim2, Lucy Masto3, Neha Nagpal1, Amaya Smole4, Dongmei Sun1, Haley Slosberg1, Margaret Minett5, Joann Vega1, Deanna Jannat-Khah1, Jane Salmon1, Michael Lockshin6, Lisa Sammaritano1 and Medha Barbhaiya1, 1Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, Englewood Cliffs, NJ, 3Hospital for Special Surgery, San Francisco, CA, 4Hospital for Special Surgery, Brooklyn, NY, 5Hospital for Special Surgery, New York, 6Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

    Background/Purpose: While UCTD is considered less clinically severe than SLE, our prior qualitative study reported that patients with UCTD experience significant psychosocial challenges (J Clin…
  • Abstract Number: 2378 • ACR Convergence 2025

    Factors Associated With Fatigue In Systemic Lupus Erythematosus: Data From The Almenara Lupus Cohort

    Alvaro Oyarce-Calderón1, Rocío Gamboa-Cárdenas2, Victor Pimentel-Quiroz3, Samira Garcia-Hirsh4, Zoila Rodríguez-Bellido5, Cesar Pastor-Asurza6, Risto Perich-Campos7, Graciela Alarcón8 and Manuel Ugarte-Gil9, 1Hospital Nacional Guillermo Almenara Irigoyen, San Miguel, Lima, Peru, 2Universidad Científica del Sur, Lima, Peru, 3Universidad Científica del Sur, San Isidro, Peru, 4Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru, 5Hospital Nacional Guillermo Almenara Irigoyen; Universidad Nacional Mayor de San Marcos, Lima, Peru, 6Hospital Nacional Guillermo Almenara Irigoyen, Lima, Pakistan, 7Hospital Nacional Guillermo Almenara Irigoyen; Universidad Nacional Mayor de San Marcos, La Molina, Peru, 8The University of Alabama at Birmingham, Oakland, CA, 9Grupo Peruano de Estudio de Enfermedades Autoinmunes Sistémicas, Universidad Científica del Sur, Lima, Peru; Hospital Guillermo Almenara Irigoyen, EsSalud, Lima, Peru, Lima, Peru

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease characterized by a wide spectrum of clinical manifestations, fatigue being one of them; it is…
  • Abstract Number: 2337 • ACR Convergence 2025

    A Mediation Analysis of Tofacitinib’s Effects on SF-36: The Roles of Fatigue, Pain, Stiffness, and Mobility in Ankylosing Spondylitis

    Xenofon Baraliakos1, Andrew G. Bushmakin2, Joseph C. Cappelleri2, Eleni Nikitopoulou3, You-Li Ling4, Mostafa Zayed5 and Jonathan Dominick Cicci6, 1Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 2Pfizer Inc., Groton, CT, 3Pfizer Hellas, Athens, Greece, 4Pfizer Inc, New York, NY, USA, New York, NY, 5Pfizer Gulf FZ LLC, Dubai, United Arab Emirates, 6Pfizer Inc., New York, NY

    Background/Purpose: Mediation modeling is used to determine mechanisms underlying the relationship between independent and dependent variables via other explanatory variables (“mediators”). Fatigue, pain, and morning…
  • Abstract Number: 1573 • ACR Convergence 2025

    Health-related quality of life over 15 years in systemic sclerosis: impact of sex and survival

    Katherine van der Wouden1, Georgy Gomon2, Rachel Knevel2, Michel Tsang-A-Sjoe3, Alexandre Voskuijl3 and Jeska de Vries-Bouwstra2, 1Leiden University Medical Center and Amsterdam University Medical Center, Leiden, Zuid-Holland, Netherlands, 2Leiden University Medical Center, Leiden, Netherlands, 3Amsterdam University Medical Center, Amsterdam, Netherlands

    Background/Purpose: Patients with systemic sclerosis (SSc) face an uncertain long‑term outlook; understanding how their health‑related quality of life (HRQoL) changes over time can help them…
  • Abstract Number: 1342 • ACR Convergence 2025

    The Impact of Age on Health-Related Quality of Life in Patients With Rheumatoid Arthritis Compared to Population Controls: A Cross-Sectional Analysis

    Saskia Truijen1, Annelies Boonen1, Sofia Ramiro2 and Marloes van Onna1, 1Maastricht University Medical Centre+ & Maastricht University, Maastricht, Limburg, Netherlands, 2Leiden University Medical Center, Bunde, Netherlands

    Background/Purpose: As the population ages, rheumatologists will increasingly care for older persons with rheumatoid arthritis (RA). Aging comes with specific challenges of which rheumatologists are…
  • Abstract Number: 1079 • ACR Convergence 2025

    Sociodemographic, Clinical, and Community-Level Deprivation Factors are Associated with Health-Related Quality of Life in Systemic Sclerosis

    Sarah Smith1, Paula Ramos2, Dulaney Wilson3, Diane Kamen4 and Richard Silver1, 1Medical University of South Carolina, Charleston, SC, 2Emory University School of Medicine, Atlanta, GA, 3Medical University of South Carolina, Charleston, 4Medical University of South Carolina, Johns Island, SC

    Background/Purpose: Systemic sclerosis (SSc) is a multisystem autoimmune disease with heterogeneous manifestations and significant impairment in health-related quality of life (HRQoL). SSc outcomes are shaped…
  • Abstract Number: 0123 • ACR Convergence 2024

    The Impact of Sedentary Behavior and Physical Activity Level on Clinical Parameters and Quality of Life in Patients with Primary Antiphospholipid Syndrome (PAPS)

    Carla Silva1 and Danieli Andrade2, 1University of Sao Paulo, Salvador, Bahia, Brazil, 2University of São Paulo, São Paulo, SP, Brazil

    Background/Purpose: PAPS is an autoimmune disease marked by thrombosis, obstetric poor outcomes and antiphospholipid antibodies. Despite treatment, APS is associated with high morbidity and mortality,…
  • Abstract Number: 0326 • ACR Convergence 2024

    Validity and Responsiveness of Core Set Measures in Idiopathic Inflammatory Myositis Based on 36-item Short Form Health Survey (SF-36)

    Maha Almackenzie1, Anushka Aggarwal2, shiri keret3, shreya Sriram4, Tanya Chandra5, Raisa Silva6, Eugenia Gkiaouraki4, Siamak Mogahadam7, Chester Oddis7 and Rohit Aggarwal8, 1Division of Rheumatology, Department of Medicine, Medical Cities of the Ministry of the Interior Riyadh, Saudi Arabia, Arlington, VA, 2Department of Rheumatology, Indraprastha Apollo Hospital, New delhi, NY, 3Rheumatology unit, Bnai-Zion medical center and the faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel., Atlit, Israel, 4Division of Rheumatology and Clinical Immunology, University of Pittsburgh Medical Center, Pittsburgh, PA, 5University of Pittsburgh Medical Center, Pittsburgh, PA, 6Internal medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, 7Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 8Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, USA, Pittsburgh, PA

    Background/Purpose: There are six core set measures (CSMs) of disease activity in patients with idiopathic inflammatory myopathies (IIM). However, there is limited data on their…
  • Abstract Number: 0355 • ACR Convergence 2024

    Improvements in Patient-Reported Outcomes After Treatment with SEL-212 in Adults with Refractory Gout: Results from Two Randomized Phase 3 Trials

    Vibeke Strand1, Puja Khanna2, Alan Kivitz3, Nana Kragh4, Aletta Falk5, Rehan Azeem6, Hugues Santin-Janin7 and Herbert Baraf8, 1Division of Immunology/Rheumatology, Stanford University, Palo Alto, CA, 2University of Michigan, Ann Arbor, MI, 3Altoona Center for Clinical Research, Duncansville, PA, 4Sobi, Kongens Lyngby, Denmark, 5Sobi, Stockholm, Sweden, 6Sobi Inc., Waltham, MA, 7Sobi, BETTENDORF (68560), France, 8Center for Rheumatology and Bone Research, Wheaton, MD

    Background/Purpose: Patients (pts) with gout have impaired health-related quality of life (HRQoL) relating to acute or chronic inflammation from elevated serum uric acid (sUA) levels.…
  • Abstract Number: 0368 • ACR Convergence 2024

    Development and Validation of a Patient-centered Self-evaluation Questionnaire in Systemic Lupus Erythematosus: LUPIN®

    Marc Scherlinger1, Jean-Francois Kleinmann1, Antonin Folliasson2, Marianne Riviere3, Raphaelle Rybak4, Sabine Malivoir5, Jean-François Viallard6, Estibaliz Lazaro7, Christophe Richez8, Irene Machelart9, Nadine Magy-Bertrand10, Audrey Gorse11, Gilles Blaison12, Julien Campagne13, Benjamin Dervieux14, Thomas Moulinet15, Roland Jaussaud16, Pascal Roblot17, Mathieu Puyade17, Amélie Servettaz18, Pauline Orquevaux18, Julie le Scanff19, DANIEL WENDLING20, Marc Andre21, Ludovic Trefond21, Perrine SMETS22, Nicolas Baillet23, Christophe Deligny24, Xavier Mariette25, ARNAUD HOT26, Emmanuelle David27, Laurent Perard28, Estelle Jean29, Sarah Permal30, Denis WAHL31, Christian Agard32, François Chasset33, Baptiste Hervier34, Pasquer Ronan2, Mickael Martin17, Ludivine Lebourg35, Frederic Renou36, Loic Raffray36, Elisabeth Diot37, Cecile Fermont38, Thierry Martin39, Anne-Sophie Korganow39, Jacques-Eric Gottenberg40, Jean Sibilia41 and Zahir Amoura42, 1Strasbourg University Hospital - National reference center for autoimmune disease, Rheumatology, Strasbourg, France, 2Hometrix Health, Paris, France, 3Association Francaise du Lupus et autres maladies autoimmunes (AFL+), Metz, France, 4Association Francaise du Lupus et autres maladies autoimmunes (AFL+), Paris, France, 5APHP Pitié Salpêtrière - National reference center for autoimmune disease, Internal Medicine, Paris, France, 6CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, FR, Bordeaux, France, 7Bordeaux University Hospital, Pessac, France, 8Université de Bordeaux, Bordeaux, France, 9CH de Bayonne - Competence center for autoimmune diseases, Internal Medicine, Bayonne, France, 10CHU de Besancon - Competence center for autoimmune diseases, Internal Medicine, Besançon, France, 11CH de Chambery - Competence center for autoimmune diseases, Internal Medicine, Chambery, France, 12CH de Colmar - Competence center for autoimmune diseases, Internal Medicine, Colmar, France, 13Hôpital Robert Schuman - Competence center for autoimmune diseases, Internal Medicine, Metz, France, 14CH de Mulhouse - Competence center for autoimmune diseases, Internal Medicine, Mulhouse, France, 15CHRU de Nancy, Vandœuvre-lès-Nancy, France, 16CHU de Nancy - Competence center for autoimmune diseases, Internal Medicine, Nancy, France, 17CHU de Poitiers - Competence center for autoimmune diseases, Internal Medicine, Poitiers, France, 18CHU de Reims - Competence center for autoimmune diseases, Internal Medicine, Reims, France, 19CH - Competence center for autoimmune diseases, Internal Medicine, Villefranche-sur-Saone, France, 20University Hospital, Besançon, France, 21CHU de Clermont-Ferrand - National reference center for autoimmune disease, Internal Medicine, Clermont-Ferrand, France, 22Clermont Ferrand University Hospital - National reference center for autoimmune disease, Internal Medicine, Clermont-Ferrand, France, 23CH de Basse-Terre - Competence center for autoimmune diseases, Internal Medicine, Basse-Terre, France, 24University Hospital of Martinique - National reference center for autoimmune disease, Internal Medicine, Fort-de-France, Martinique, 25Service de Rhumatologie, Hôpital Bicêtre, AP-HP, Le Kremlin Bicetre, France, 26Service de Médecine interne, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France, 27HCL - Croix Rousse, Internal Medicine, Lyon, France, 28Hopital Saint-Joseph, Internal Medicine, Lyon, France, 29APHM - La Timone, Internal Medicine, Marseille, France, 30CH Mayotte - CH Wallis-et-Futuna, Internal Medicine, Mamoudzou, Mayotte, 31Lorraine University, Nancy, France, 32CHU de Nantes - National reference center for autoimmune disease, Internal Medicine, Nantes, France, 33Dermatology, Hôpital Tenon, Paris, France, 34APHP Saint-Louis - National reference center for autoimmune disease, Internal Medicine, Paris, France, 35CHU de Rouen, Internal Medicine, Rouen, France, 36CHU La Réunion - Competence center for autoimmune diseases, Internal Medicine, Saint-Denis, Reunion, 37CHU de Tours - Competence center for autoimmune diseases, Internal Medicine, Tours, France, 38CH de Valence - Competence center for autoimmune diseases, Internal Medicine, Valence, France, 39Strasbourg University Hospital, National reference center for autoimmune disease, Clinical Immunology, Strasbourg, France, 40Rheumatology Department, Strasbourg University Hospital,, Strasbourg, France, 41Strasbourg University Hospital, National reference center for autoimmune disease, Rheumatology, Strasbourg, France, 42French National Reference Centre for Systemic Lupus Erythematosus, Pitié-Salpêtrière Hospital, Paris, France

    Background/Purpose: Systemic Lupus Erythematosus (SLE) features unpredictable disease activity fluctuations, making flare hard to detect and significantly impairing quality of life. This highlights the need…
  • Abstract Number: 1160 • ACR Convergence 2024

    Short Form-36 Psychometric Properties in Idiopathic Inflammatory Myopathies: Reliability, Validity and Responsiveness

    shiri keret1, Anushka Aggarwal2, Maha Almackenzie3, Tanya Chandra4, Raisa Silva5, Eugenia Gkiaouraki6, Nantakarn Pongtarakulpanit7, shreya Sriram6, Chester Oddis7 and Rohit Aggarwal8, 1Rheumatology unit, Bnai-Zion medical center and the faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel., Atlit, Israel, 2Department of Rheumatology, Indraprastha Apollo Hospital, New delhi, NY, 3Division of Rheumatology, Department of Medicine, Medical Cities of the Ministry of the Interior Riyadh, Saudi Arabia, Arlington, VA, 4University of Pittsburgh Medical Center, Pittsburgh, PA, 5Internal medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, 6Division of Rheumatology and Clinical Immunology, University of Pittsburgh Medical Center, Pittsburgh, PA, 7Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 8Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, USA, Pittsburgh, PA

    Background/Purpose: The quality of life, as measured by the Short Form-36 (SF-36), is reduced in patients with idiopathic inflammatory myopathies (IIM). Although endorsed by the…
  • Abstract Number: 1380 • ACR Convergence 2024

    Rapid, Clinically Meaningful Pain Improvements Are Associated with Improvements in Other Patient-Reported Outcomes in RA Patients Treated with Upadacitinib

    Manish Jain1, Arthur Kavanaugh2, Angela Crowley3, Avani Joshi4, Patrick Zueger5, Diane Caballero6, Andrew Garrison6 and Peter C. Taylor7, 1Endeavor Health Swedish Hospital and Captain James A, Chicago, IL, 2University of California San Diego, La Jolla, CA, 3Illinois Bone and Joint Institute, Hinsdale Orthopaedics, Hinsdale, IL, 4AbbVie, North Chicago, IL, 5AbbVie Inc, North Chicago, IL, 6AbbVie Inc., North Chicago, IL, 7University of Oxford, Oxford, United Kingdom

    Background/Purpose: Pain is a crucial symptom for patients with RA; early and effective treatment can help alleviate it.1 In this post hoc analysis, we investigated…
  • Abstract Number: 1353 • ACR Convergence 2023

    Sexual Dysfunction in Women with Systemic Lupus Erythematosus: A Cross-Sectional Multicentre Study

    Maria Helena Lourenco1, Rita Torres2, Santiago Rodrigues-Manica3, Vanessa Fraga4, Ana Catarina Abreu5, Roberto Costa6, Carolina Ochôa Matos7, Beatriz Mendes8, Beatriz Samões9, Inês Silva1, Fernando Pimentel-Santos10, Manuela Costa1, Jaime Branco11 and Alexandre Sepriano12, 1Hospital Egas Moniz, Lisbon, Portugal, 2Hospital Egas Moniz, Lisboa, Portugal, 3Hospital Egas Moniz, CHLO, Lisboa, Portugal, 4Hospital Garcia de Orta, Nogueira da Regedoura, Portugal, 5Hospital Garcia de Orta, Lisboa, Portugal, 6Centro Hospitalar Lisboa Norte, Lisboa, Portugal, 7Centro Académico de Medicina de Lisboa, Lisbon, Portugal, 8Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal, 9Centro Hospitalar de Vila Nova de Gaia, Vila Nova de Gaia, Portugal, 10NOVA Medical School; Universidade NOVA e Lisboa, Lisboa, Portugal, 11CHLO, EPE - Hospital Egas Moniz, Lisbon, Portugal, 12Leiden University Medical Centre, Portela Loures, Portugal

    Background/Purpose: Due to its multisystemic involvement, systemic lupus erythematosus (SLE) can have a significant impact on patients' quality of life (QoL). Sexual (dis)function is a…
  • Abstract Number: 1480 • ACR Convergence 2023

    Demographic and Clinical Characteristics of Patients with LN: A Multicenter Study from the Gulf Region

    Jamal Al-Saleh1, Faisal Elbadawi1, Rajaie Namas2, Samar Al-Emadi3, Khalid A. Alnaqbi4, Humaid A. Al-Wahshi5, Amjad Alkadi6, Suad Hannawi7, Mohamed Hamouda8, Averyan Vasylyev8, Arwa Al-Shujairi8, Reem Al-Jayyousi9 and Munther Khamashta8, 1Dubai Hospital, Department of Rheumatology, Dubai, United Arab Emirates, 2Cleveland Clinic Abu Dhabi, Department of Rheumatology, Abu Dhabi, United Arab Emirates, 3Hamad Medical Corporation, Department of Rheumatology, Doha, Qatar, 4Tawam Hospital, Department of Rheumatology, Al Ain, United Arab Emirates, 5The Royal Hospital, Department of Rheumatology, Muscat, Oman, 6Ministry of Health, Kuwait, Kuwait, 7Kuwait Hospital, Department of Rheumatology, Dubai, United Arab Emirates, 8GSK Gulf, Medical Affairs Department, Dubai, United Arab Emirates, 9Mohamed Bin Rashid University of Medicine and Health Sciences, College of Medicine, Dubai, United Arab Emirates, and Mediclinic Parkview, Dubai, United Arab Emirates

    Background/Purpose: Data from limited studies of LN in the Gulf region suggest that LN manifests more severely in this region than in Caucasian populations, yet…
  • Abstract Number: 1832 • ACR Convergence 2023

    Prevalence of Musculoskeletal Manifestations in Post-acute COVID 19 Patients and Their Quality of Life at Kenyatta National Hospital

    Miriam Kiyiapi, Omondi Oyoo, Peter Oyiro and Frederick Wangai, University of Nairobi, Nairobi, Kenya

    Background/Purpose: Since its discovery in Wuhan, China, severe acute respiratory syndrome coronavirus 2 (SARS CoV 2) has ravaged the globe on an unprecedented scale. While…
  • 1
  • 2
  • 3
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology